1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Microalbuminuria Global Clinical Trials Review, H2, 2015

Microalbuminuria Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 87 pages

Microalbuminuria Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Microalbuminuria Global Clinical Trials Review, H2, 2015" provides an overview of Microalbuminuria clinical trials scenario. This report provides top line data relating to the clinical trials on Microalbuminuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Microalbuminuria Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Microalbuminuria 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Microalbuminuria 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Microalbuminuria Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Steno Diabetes Center A/S 32
Clinical Trial Overview of Steno Diabetes Center A/S 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Takeda Pharmaceutical Company Limited 34
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 34
Sanofi 35
Clinical Trial Overview of Sanofi 35
Bristol-Myers Squibb Company 36
Clinical Trial Overview of Bristol-Myers Squibb Company 36
Alfa Wassermann S.p.A 37
Clinical Trial Overview of Alfa Wassermann S.p.A 37
Fondazione Mario Negri Sud 38
Clinical Trial Overview of Fondazione Mario Negri Sud 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
AstraZeneca Plc 40
Clinical Trial Overview of AstraZeneca Plc 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Hospital de Clinicas de Porto Alegre 42
Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 42
Akershus University Hospital 43
Clinical Trial Overview of Akershus University Hospital 43
Asahikawa Medical College 44
Clinical Trial Overview of Asahikawa Medical College 44
Charles Drew University of Medicine and Science 45
Clinical Trial Overview of Charles Drew University of Medicine and Science 45
Chengdu University of Traditional Chinese Medicine 46
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 46
Chiba University Hospital 47
Clinical Trial Overview of Chiba University Hospital 47
Chongqing Medical University (Inactive) 48
Clinical Trial Overview of Chongqing Medical University (Inactive) 48
Erasmus MC 49
Clinical Trial Overview of Erasmus MC 49
Gujarat Ayurved University 50
Clinical Trial Overview of Gujarat Ayurved University 50
Hospital Universitari Vall d'Hebron 51
Clinical Trial Overview of Hospital Universitari Vall d'Hebron 51
Five Key Clinical Profiles 52
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 87

List of Tables
Microalbuminuria Therapeutics, Global, Clinical Trials by Region, 2015* 7
Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Microalbuminuria Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Microalbuminuria Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Microalbuminuria Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2015* 32
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 34
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 35
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 36
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015* 37
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione Mario Negri Sud, 2015* 38
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 39
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 40
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 41
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015* 42
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Akershus University Hospital, 2015* 43
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahikawa Medical College, 2015* 44
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles Drew University of Medicine and Science, 2015* 45
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015* 46
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2015* 47
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chongqing Medical University (Inactive), 2015* 48
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 49
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2015* 50
Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitari Vall d'Hebron, 2015* 51

List of Figures
Microalbuminuria Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Microalbuminuria Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.